DCwire Micro-guidewire
Shanghai Achieva Medical Suzhou Co., Ltd. · Decision date Mar 16, 2026
What did the FDA decide?
FDA records K252122 as a 510(k) premarket notification, with a decision dated Mar 16, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 16, 2026
Regulatory record facts
- Identifier
- K252122
- Regulatory pathway
- 510(k) premarket notification
- Product code
- MOF
- Decision code
- SESE
- Decision date
- Mar 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Guide, Wire, Catheter, Neurovasculature.
- Product code
- MOF
- FDA device class
- 2
FDA decision timeline
K252122 received
Application receipt date recorded by FDA.
K252122 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MOF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Aristotle 65 MacrowireK254181 | Scientia Vascular | 510(k) clearance | Sep 16, 2026 | FDA |
35 Helix GuidewireK260751 | Piraeus Medical, Inc. | 510(k) clearance | Aug 27, 2026 | FDA |
Willow 12 GuidewireK262424 | Arbor Endovascular, LLC | 510(k) clearance | Aug 14, 2026 | FDA |
Aristotle Mini GuidewireK260223 | Scientia Vascular, Inc. | 510(k) clearance | Aug 6, 2026 | FDA |
Drivewire 35 GuidewireK254006 | Rapid-Medical , Ltd. | 510(k) clearance | Jul 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shanghai Achieva Medical Suzhou Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suzhou
Sources and methodology
- Original FDA record: K252122
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


